B. Meiklejohn

Quality by Design for Biotechnology Products

A. Rathore, R. Greene, J. Mercer, 2009 .

Improved methods for separation of human cytokeratins.

G. S. Wilson, B. Meiklejohn, R. Nagle, 1990, Life sciences.

A Highly Sensitive and Drug-Tolerant Anti-Drug Antibody Screening Assay for Ixekizumab using Affinity Capture Elution.

B. Meiklejohn, Y. Qian, K. Papp, 2016, Journal of Investigative Dermatology.

Reversibly immobilized glucose oxidase in the amperometric flow-injection determination of glucose.

G. S. Wilson, B. Meiklejohn, B. S. Hill, 1987, Analytical chemistry.

Recommendations regarding technical standards for follow-on biologics: comparability, similarity, interchangeability

J. M. Beals, B. Meiklejohn, J. Towns, 2009, Current medical research and opinion.

Fluorescent dye assay for detection of DNA in recombinant protein products.

B. Meiklejohn, T. Burke, R. Bolger, 1997, BioTechniques.

5-iodonaphthyl-1-azide labeling of plasma membrane proteins adjacent to specific sites via energy transfer.

B. Meiklejohn, B. Barisas, D. Roess, 1997, Biochimica et biophysica acta.

Luteinizing hormone receptors are associated with non-receptor plasma membrane proteins on bovine luteal cell membranes.

B. Meiklejohn, B. Barisas, C. Brady, 1998, Biochimica et biophysica acta.